Your browser doesn't support javascript.
loading
Corrigendum to "Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases".
Kumar, Manoj; Nagpal, Ravinder; Kumar, Rajesh; Hemalatha, R; Verma, Vinod; Kumar, Ashok; Chakraborty, Chaitali; Singh, Birbal; Marotta, Francesco; Jain, Shalini; Yadav, Hariom.
Afiliação
  • Kumar M; Department of Microbiology & Immunology, National Institute of Nutrition, Hyderabad, India.
  • Nagpal R; Department of Biotechnology, JMIT Institute of Technology, Radaur, Haryana, India.
  • Kumar R; Department of Microbiology & Immunology, National Institute of Nutrition, Hyderabad, India.
  • Hemalatha R; Department of Microbiology & Immunology, National Institute of Nutrition, Hyderabad, India.
  • Verma V; Research and Development Unit, National Heart Centre, Singapore.
  • Kumar A; Department of Zoology, M.L.K. Post-Graduate College, Balrampur, India.
  • Chakraborty C; Department of Biotechnology, ITS Paramedical College, Ghaziabad, India.
  • Singh B; Indian Veterinary Research Institute, Regional Station, Palampur, India.
  • Marotta F; Hepato-Gastroenterology Unit, S. Giuseppe Hospital, Vittore, Milano, Italy.
  • Jain S; National Institute of Diabetes and Digestive and Kidney Diseases, NIH, MD, USA.
  • Yadav H; National Institute of Diabetes and Digestive and Kidney Diseases, NIH, MD, USA.
J Diabetes Res ; 2022: 3952529, 2022.
Article em En | MEDLINE | ID: mdl-35399706
ABSTRACT
[This corrects the article DOI 10.1155/2012/902917.].

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article